Logo image of BPTS

BIOPHYTIS SA-ADR (BPTS) Stock Price, Quote, News and Overview

NASDAQ:BPTS - Nasdaq - US09076G2030 - ADR - Currency: USD

8.22  -1.48 (-15.28%)

After market: 7.92 -0.3 (-3.65%)

BPTS Quote, Performance and Key Statistics

BIOPHYTIS SA-ADR

NASDAQ:BPTS (4/25/2024, 8:00:01 PM)

After market: 7.92 -0.3 (-3.65%)

8.22

-1.48 (-15.28%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High168.8
52 Week Low8.05
Market Cap94.20M
Shares11.46M
Float1.40B
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-25 2024-09-25
IPO07-13 2015-07-13


BPTS short term performance overview.The bars show the price performance of BPTS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

BPTS long term performance overview.The bars show the price performance of BPTS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of BPTS is 8.22 USD. In the past month the price decreased by -41.29%. In the past year, price decreased by -94.66%.

BIOPHYTIS SA-ADR / BPTS Daily stock chart

BPTS Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About BPTS

Company Profile

BPTS logo image Biophytis SA operates as a clinical-stage biotechnology company. The company is headquartered in Paris, Ile-De-France and currently employs 26 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Company Info

BIOPHYTIS SA-ADR

14 avenue de l'Opera

Paris ILE-DE-FRANCE 75252 FR

CEO: Stanislas Veillet

Employees: 26

Company Website: https://www.biophytis.com/

Phone: 33141836600

BIOPHYTIS SA-ADR / BPTS FAQ

What is the stock price of BIOPHYTIS SA-ADR today?

The current stock price of BPTS is 8.22 USD. The price decreased by -15.28% in the last trading session.


What is the ticker symbol for BIOPHYTIS SA-ADR stock?

The exchange symbol of BIOPHYTIS SA-ADR is BPTS and it is listed on the Nasdaq exchange.


On which exchange is BPTS stock listed?

BPTS stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BIOPHYTIS SA-ADR stock?

8 analysts have analysed BPTS and the average price target is 0.38 USD. This implies a price decrease of -95.36% is expected in the next year compared to the current price of 8.22. Check the BIOPHYTIS SA-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIOPHYTIS SA-ADR worth?

BIOPHYTIS SA-ADR (BPTS) has a market capitalization of 94.20M USD. This makes BPTS a Micro Cap stock.


How many employees does BIOPHYTIS SA-ADR have?

BIOPHYTIS SA-ADR (BPTS) currently has 26 employees.


What are the support and resistance levels for BIOPHYTIS SA-ADR (BPTS) stock?

BIOPHYTIS SA-ADR (BPTS) has a resistance level at 12.53. Check the full technical report for a detailed analysis of BPTS support and resistance levels.


Should I buy BIOPHYTIS SA-ADR (BPTS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIOPHYTIS SA-ADR (BPTS) stock pay dividends?

BPTS does not pay a dividend.


When does BIOPHYTIS SA-ADR (BPTS) report earnings?

BIOPHYTIS SA-ADR (BPTS) will report earnings on 2024-09-25.


What is the Price/Earnings (PE) ratio of BIOPHYTIS SA-ADR (BPTS)?

BIOPHYTIS SA-ADR (BPTS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.8).


BPTS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

BPTS Financial Highlights

Over the last trailing twelve months BPTS reported a non-GAAP Earnings per Share(EPS) of -7.8. The EPS increased by 63.64% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -134.02%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%75%
Sales Q2Q%N/A
EPS 1Y (TTM)63.64%
Revenue 1Y (TTM)N/A

BPTS Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 38% to BPTS. The Buy consensus is the average rating of analysts ratings from 8 analysts.


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts37.5
Price Target0.38 (-95.38%)
EPS Next Y-133.33%
Revenue Next YearN/A